Bruce G. Robinson
The University of Sydney · 310 works · 18,114 citations · h-index 71
Top works
- Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
- Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- Clinical Presentation and Penetrance of Pheochromocytoma/Paraganglioma Syndromes
- HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome
- A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas
- Efficacy of Selpercatinib in RET -Altered Thyroid Cancers
- 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer
- Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta.
- Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene
- Allelic imbalance, including deletion ofPTEN/MMAC1, at the Cowden disease locus on 10q22-23, in hamartomas from patients with cowden syndrome and germlinePTEN mutation
- Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
- Differential Nuclear and Cytoplasmic Expression of PTEN in Normal Thyroid Tissue, and Benign and Malignant Epithelial Thyroid Tumors
- Somatic mutations in the RET proto‐oncogene in sporadic medullary thyroid carcinoma
- Vasopressin mRNA in the Suprachiasmatic Nuclei: Daily Regulation of Polyadenylate Tail Length
- HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours
- Genotype‐phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium
- Responses to access block in Australia: Royal North Shore Hospital
- Intraoperative parathyroid hormone monitoring fails to detect double parathyroid adenomas: A 2-institution experience
- Increasing incidence of thyroid cancer is due to increased pathologic detection